Literature DB >> 17558476

Stealth dendrimers for antiarrhythmic quinidine delivery.

Hu Yang1, Stephanie T Lopina.   

Abstract

Dendrimers have been attracting growing attention because of their unique well-defined globular nanoscale architecture and numerous functional groups on the surface. Attachment of PEG to the dendrimer generates stealth dendrimers, which have promising structural advantages for drug delivery. In this study, synthetic methods were explored to deliver antiarrhythmic quinidine by stealth dendrimers. In particular, quinidine was covalently attached to anionic G2.5 and cationic G3.0 polyamidoamine (PAMAM) dendrimers via a glycine spacer, respectively. The resulting quinidine-PAMAM-PEG conjugates were characterized and confirmed by FT-IR and (1)H-NMR. In vitro hydrolysis was carried out in pH 7.4 PBS buffer at 37 degrees C to confirm the bioavailability of the conjugated quinidine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17558476     DOI: 10.1007/s10856-007-3144-0

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  12 in total

1.  Designing dendrimers for drug delivery.

Authors: 
Journal:  Pharm Sci Technol Today       Date:  1999-10

Review 2.  Dendrimers for pharmaceutical and biomedical applications.

Authors:  Hu Yang; Weiyuan John Kao
Journal:  J Biomater Sci Polym Ed       Date:  2006       Impact factor: 3.517

3.  Terminal groups in Starburst dendrimers: activation and reactions with proteins.

Authors:  P Singh
Journal:  Bioconjug Chem       Date:  1998 Jan-Feb       Impact factor: 4.774

4.  Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications.

Authors:  R Esfand; D A. Tomalia
Journal:  Drug Discov Today       Date:  2001-04-01       Impact factor: 7.851

5.  Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo.

Authors:  A U Bielinska; A Yen; H L Wu; K M Zahos; R Sun; N D Weiner; J R Baker; B J Roessler
Journal:  Biomaterials       Date:  2000-05       Impact factor: 12.479

6.  In vitro enzymatic stability of dendritic peptides.

Authors:  Hu Yang; Stephanie T Lopina
Journal:  J Biomed Mater Res A       Date:  2006-02       Impact factor: 4.396

7.  Application of a macromolecular contrast agent for detection of alterations of tumor vessel permeability induced by radiation.

Authors:  Hisataka Kobayashi; Koen Reijnders; Sean English; Alexander T Yordanov; Diane E Milenic; Anastasia L Sowers; Deborah Citrin; Murali C Krishna; Thomas A Waldmann; James B Mitchell; Martin W Brechbiel
Journal:  Clin Cancer Res       Date:  2004-11-15       Impact factor: 12.531

8.  Enhanced cellular uptake of a triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimers.

Authors:  Latha M Santhakumaran; Thresia Thomas; T J Thomas
Journal:  Nucleic Acids Res       Date:  2004-04-15       Impact factor: 16.971

9.  Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide.

Authors:  Robert J Marano; Norbert Wimmer; Philip S Kearns; Bradley G Thomas; Istvan Toth; Meliha Brankov; P Elizabeth Rakoczy
Journal:  Exp Eye Res       Date:  2004-10       Impact factor: 3.467

10.  Penicillin V-conjugated PEG-PAMAM star polymers.

Authors:  Hu Yang; Stephanie T Lopina
Journal:  J Biomater Sci Polym Ed       Date:  2003       Impact factor: 3.517

View more
  10 in total

1.  Dendrimer-triglycine-EGF nanoparticles for tumor imaging and targeted nucleic acid and drug delivery.

Authors:  Quan Yuan; Eunmee Lee; W Andrew Yeudall; Hu Yang
Journal:  Oral Oncol       Date:  2010-08-21       Impact factor: 5.337

Review 2.  Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis.

Authors:  Hu Yang
Journal:  Pharm Res       Date:  2010-07-01       Impact factor: 4.200

3.  Poly (ethylene glycol)-armed hyperbranched polyoxetanes for anticancer drug delivery.

Authors:  Khushboo Sharma; Olga Yu Zolotarskaya; Kenneth J Wynne; Hu Yang
Journal:  J Bioact Compat Polym       Date:  2012-11       Impact factor: 1.756

4.  Stealth dendrimers for drug delivery: correlation between PEGylation, cytocompatibility, and drug payload.

Authors:  Hu Yang; Stephanie T Lopina; Linda P DiPersio; Steven P Schmidt
Journal:  J Mater Sci Mater Med       Date:  2007-10-19       Impact factor: 3.896

5.  Synthesis and characterization of thermoresponsive polyamidoamine-polyethylene glycol-poly(D,L-lactide) core-shell nanoparticles.

Authors:  Arunvel Kailasan; Quan Yuan; Hu Yang
Journal:  Acta Biomater       Date:  2009-08-27       Impact factor: 8.947

6.  Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity.

Authors:  Yoonkyung Kim; Athena M Klutz; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2008-07-09       Impact factor: 4.774

7.  Surface engineering of macrophages with nanoparticles to generate a cell-nanoparticle hybrid vehicle for hypoxia-targeted drug delivery.

Authors:  Christopher A Holden; Quan Yuan; W Andrew Yeudall; Deborah A Lebman; Hu Yang
Journal:  Int J Nanomedicine       Date:  2010-02-02

Review 8.  Targeted nanosystems: Advances in targeted dendrimers for cancer therapy.

Authors:  Hu Yang
Journal:  Nanomedicine       Date:  2015-12-17       Impact factor: 5.307

9.  Substantial cell apoptosis provoked by naked PAMAM dendrimers in HER2-positive human breast cancer via JNK and ERK1/ERK2 signalling pathways.

Authors:  Hadeel Kheraldine; Ishita Gupta; Hashim Alhussain; Aayesha Jabeen; Farhan S Cyprian; Saghir Akhtar; Ala-Eddin Al Moustafa; Ousama Rachid
Journal:  Comput Struct Biotechnol J       Date:  2021-05-07       Impact factor: 7.271

10.  Dendrimer-enabled transformation of Anaplasma phagocytophilum.

Authors:  Aminat T Oki; David Seidman; Michael G Lancina; Manoj K Mishra; Rangaramanujam M Kannan; Hu Yang; Jason A Carlyon
Journal:  Microbes Infect       Date:  2015-09-11       Impact factor: 9.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.